Carterra Advances Lab-In-The-Loop Drug Discovery Through New Scientific Collaboration

What happened: Carterra announced a research collaboration with AstraZeneca to develop hardware and software for lab-in-the-loop drug discovery, connecting lab systems and data with AI-driven discovery Why it matters: The effort targets a barrier the scientific and AI communities cite for AI in drug discovery: consistent, comparable experimental data at scale. AstraZeneca is among the pharma companies pursuing these approaches. Key numbers: Announced October 07, 2026. A July 2026 Leerink Partners report described lab-in-the-loop as an emerging paradigm reshaping antibody discovery. Market: -0.8% by next close ($158.78 on Oct 8), -10.6% YTD

Carterra announced a research collaboration with AstraZeneca to develop hardware and software for lab-in-the-loop drug discovery, connecting lab systems and data with AI-driven discovery

The effort targets a barrier the scientific and AI communities cite for AI in drug discovery: consistent, comparable experimental data at scale. AstraZeneca is among the pharma companies pursuing these approaches. Key numbers: Announced October 07, 2026. A July 2026 Leerink Partners report described lab-in-the-loop as an emerging paradigm reshaping antibody discovery. Market: -0.8% by next close ($158.78 on Oct 8), -10.6% YTD